Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor. Download Section Flyer
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Calcium Channels as Therapeutic Targets (Deadline: 25 July 2025)
- Fluoroquinolones (Deadline: 25 July 2025)
- Innovations in Therapeutic Strategies for Retinal and Neurodegenerative Diseases (Deadline: 25 July 2025)
- Novel Therapeutic Approaches for Chronic Urticaria: Advances and Challenges (Deadline: 28 July 2025)
- Recent Advances in Cancer Diagnosis and Therapy (Deadline: 30 July 2025)
- Drug Discovery, Development, and Synthesis for Glioblastoma (Deadline: 30 July 2025)
- Pharmacological Advances for Treatment in Hypertension 2.0 (Deadline: 31 July 2025)
- The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement (Deadline: 31 July 2025)
- Recent Advances in Ocular Pharmacology (Deadline: 31 July 2025)
- Novel Therapeutic Targets and Strategies for Drug Addiction and Medication-Induced Toxicity (Deadline: 31 July 2025)
- Advancing Cardio-Oncology: Mechanisms of Cardiotoxicity and Therapeutic Options for Old and New Anticancer Drugs (Deadline: 31 July 2025)
- Emerging Therapeutics for the Prevention of Chemotherapy-Induced Cardiotoxicity: Advances and Future Perspectives (Deadline: 31 July 2025)
- Advancements in Cardiovascular and Antidiabetic Drug Therapy, 2nd Edition (Deadline: 31 July 2025)
- Scientific Evidence-Based Applications of Polyamines in Pharmaceuticals Science (Deadline: 5 August 2025)
- Innovative Tools for Drug Analysis and Therapeutic Drug Monitoring (TDM) (Deadline: 15 August 2025)
- Potential Therapeutic Targets for the Management of Diabetes Mellitus, Obesity and Cancer (Deadline: 15 August 2025)
- Glial Cells as Drug Targets for Schizophrenia (Deadline: 15 August 2025)
- Psychiatric Drug Treatment and Drug Addiction (Deadline: 25 August 2025)
- Tumor Immunopharmacology (Deadline: 25 August 2025)
- Neuropsychiatric Disorders: Pharmacological Aspects (Deadline: 25 August 2025)
- Pharmacological Approaches of Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer (Deadline: 25 August 2025)
- Pharmacology and Mechanism of Action of Peptides in the Brain (Deadline: 25 August 2025)
- Therapeutic Drug Monitoring and Adverse Drug Reactions: 2nd Edition (Deadline: 25 August 2025)
- Challenges and Emerging Trends in Photopharmacology (Deadline: 25 August 2025)
- Advances in Smooth Muscle Pharmacology (Deadline: 25 August 2025)
- Application of MRI in Drug Metabolism and Pharmacokinetics (Deadline: 25 August 2025)
- Lithium in Psychiatric Therapy: Celebrating 75th Anniversary (Deadline: 28 August 2025)
- P2X Receptors and Their Pharmacology (Deadline: 31 August 2025)
- Advances in Cancer Treatment and Toxicity (Deadline: 31 August 2025)
- Antibiotic Resistance and Misuse (Deadline: 31 August 2025)
- Pharmacotherapeutics of Sarcoidosis (Deadline: 31 August 2025)
- Advances in Antiparasitic Drug Research (Deadline: 31 August 2025)
- New Targets and Experimental Therapeutic Approaches for Cancers (Deadline: 10 September 2025)
- Novel Antimicrobials and the Antimicrobial Activity: New Advances (Deadline: 15 September 2025)
- Pharmaceutical Strategy for Mood Disorders (Deadline: 22 September 2025)
- Drug Safety and Risk Management in Clinical Practice (Deadline: 25 September 2025)
- Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances (Deadline: 25 September 2025)
- Pharmacogenomics for Precision Medicine (Deadline: 25 September 2025)
- Drug Treatment of Cancers (Deadline: 25 September 2025)
- Psychedelics: A New Drug Candidate for Treating Mental Illness (Deadline: 25 September 2025)
- Novel Drug Compositions for Ischemic Stroke: Mechanisms and Clinical Applications (Deadline: 25 September 2025)
- Next-Generation Antibiotic Strategies Against Drug-Resistant Bacteria (Deadline: 25 September 2025)
- Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes (Deadline: 26 September 2025)
- Recent Advances in Drug Metabolism, Transport, and Pharmacokinetics (Deadline: 30 September 2025)
- Advances in Pharmacotherapy for Nasal Disorders in Rhinology (Deadline: 30 September 2025)
- Advancements and Possibilities for the Treatment of Idiopathic Inflammatory Myopathies (Deadline: 30 September 2025)
- Advances in Ophthalmic Drug Discovery and Delivery: From Targets to Treatments (Deadline: 30 September 2025)
- Advancements in Cardiometabolic Pharmacology Research (Deadline: 30 September 2025)
- Pharmacotherapy for Alzheimer’s Disease (Deadline: 5 October 2025)
- Melatonin Applications in Pharmaceutical Science (Deadline: 5 October 2025)
- Affective Disorders Psychopharmacology (Deadline: 15 October 2025)
- Sirtuins as Novel Biological Targets for Pharmacological Intervention in Physiology and Pathology—2nd Edition (Deadline: 20 October 2025)
- Pharmaceutical Modeling and Real-World Data: Advancing Prescribing and Monitoring (Deadline: 22 October 2025)
- Adjuvant Therapies for Cancer Treatment: 2nd Edition (Deadline: 22 October 2025)
- Pharmacotherapy of Thromboembolism (Deadline: 25 October 2025)
- Pharmacological Therapies for Stress-Related Disorders and Autism Spectrum Disorder (Deadline: 25 October 2025)
- New and Emerging Treatment Strategies for Gastrointestinal Diseases (Deadline: 25 October 2025)
- Ion Channels as Pharmacological Targets in Cancer (Deadline: 25 October 2025)
- Exploring the Anticancer and Immunomodulatory Mechanisms of Phytochemicals and Natural Bioactive Compounds (Deadline: 25 October 2025)
- Endocrine Diseases and Pharmacogenomics (Deadline: 25 October 2025)
- Therapeutic Potential of Scopolamine and Its Adverse Effect (Deadline: 25 October 2025)
- Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success, 2nd Edition (Deadline: 25 October 2025)
- Innovative Approaches to GABAergic Drug Discovery: From Molecular Mechanisms to Advanced Therapeutics (Deadline: 25 October 2025)
- Challenges in Discovering Innovations Related to Biofilms: Virulence, Spread, Control Strategies and Treatment (Deadline: 25 October 2025)
- Precision Oncology: Targeting Molecular Subtypes in Cancer Therapy (Deadline: 30 October 2025)
- Advances in Prostate Cancer Therapeutics (Deadline: 30 October 2025)
- Pharmaceuticals for Inflammatory Bowel Disease (IBD) (Deadline: 31 October 2025)
- Purinergic Signaling in Cancer Therapy: From Mechanisms to Targeting Strategies (Deadline: 31 October 2025)
- Drug-Induced and Herbal Hepatotoxicity and Methods of Its Prevention: 2nd Edition (Deadline: 31 October 2025)
- Therapeutic Potential of Chalcone Derivatives (Deadline: 10 November 2025)
- Pharmacotherapy of Prostate Cancer (Deadline: 15 November 2025)
- Optimized or Precise Pharmacological Treatment of Bipolar Disorder (Deadline: 20 November 2025)
- Pharmacotherapy of Diseases Affecting Urinary Tract (Deadline: 20 November 2025)
- Discovery of Novel Antidepressants and Anxiolytics (Deadline: 25 November 2025)
- New Findings in Pharmacogenomics of Neuropsychiatric Disorders (Deadline: 25 November 2025)
- Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends (Deadline: 25 November 2025)
- New Development in Pharmacotherapy of Kidney Diseases (Deadline: 25 November 2025)
- Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine (Deadline: 25 November 2025)
- Novel Therapeutic Strategies for Alzheimer’s Disease Treatment (Deadline: 25 November 2025)
- Pharmaceutical Approaches to Orofacial Pain and Chronic Pain Conditions (Deadline: 25 November 2025)
- Epithelial Plasticity and Therapy Resistance in Cancer (Deadline: 25 November 2025)
- Pharmacovigilance Insights: Addressing Drug Misuse and Enhancing Drug Safety (Deadline: 25 November 2025)
- Pharmacology and Toxicology of Opioids, 2nd Edition (Deadline: 25 November 2025)
- Antimicrobial Therapies Affect the Microbial Ecosystems Within Our Body: The Urinary Microbiome and Urolithiasis (Deadline: 25 November 2025)
- Next-Generation Targeted Therapy: vNARs as Drug Carriers and Intracellular Neutralizing Agents (Deadline: 28 November 2025)
- New Insights of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Biomedical Applications (Deadline: 30 November 2025)
- Advances in Antibody–Drug Conjugates (Deadline: 30 November 2025)
- Comprehensive Strategies in Cancer Immunotherapy (Deadline: 30 November 2025)
- Green Synthesis and Biological Applications of Metal Nanoparticles Influenced by Different Seasonal Periods (Deadline: 30 November 2025)
- Pharmacological Strategies to Modulate Symptoms in Autism Spectrum Disorders (ASD) (Deadline: 30 November 2025)
- Population Pharmacokinetics and Pharmacogenetics (Deadline: 10 December 2025)
- Management of Pain in Oral Mucositis (Deadline: 20 December 2025)
- Cancer Pain—from Novel Mechanisms to Clinical Management (Deadline: 25 December 2025)
- Treatment for HPV-Associated Cervical Cancer: Novel Therapeutic Strategies (Deadline: 25 December 2025)
- Pharmacotherapy of Endometriosis (Deadline: 31 December 2025)
- Pharmacology of Heart Failure (Deadline: 31 December 2025)
- Drug Target Exploration and Drug Design & Development Based on Small Molecule (Deadline: 31 December 2025)
- Applications of Nerve Growth Factor in Pharmaceuticals (Deadline: 31 December 2025)
- Infectious Disease Epidemiology and Pharmaceutical Development in the Era of Antimicrobial Resistance (AMR) (Deadline: 31 December 2025)
- Emerging Therapies for Diabetes and Obesity (Deadline: 15 January 2026)
- The Pharmacology of Bisphosphonates: New Advances (Deadline: 20 January 2026)
- Biological and Pharmacological Research on Indole-3-Carbinol (I3C) and Its Derivatives (Deadline: 20 January 2026)
- Pharmacological Activities and Therapeutic Potential of Novel Drug Derivatives (Deadline: 20 January 2026)
- Pharmacoepidemiology and Pharmacovigilance in Drug Therapy: New Issues, Challenges, and Applications (Deadline: 25 January 2026)
- Research Progress and Drug Intervention Strategies for Oral Health-Related Diseases (Deadline: 25 January 2026)
- Clinical Advances in the Neuropharmacological Treatment of Substance Use Disorders: 2nd Edition (Deadline: 25 January 2026)
- Advances in Drug Treatment for Pediatric Gastroenterology (Deadline: 25 January 2026)
- Pharmacogenomics and Ethnic Diversity: Optimizing Drug Response Across Populations (Deadline: 25 January 2026)
- Osteosarcomas: Treatment Strategies, 2nd Edition (Deadline: 26 January 2026)
- Pharmacological Modulation of Inflammation in Autoimmune Diseases and Cancer (Deadline: 27 January 2026)
- Drug Candidates for the Treatment of Oral Cancer and Oral Cancer Pain, 2nd Edition (Deadline: 27 January 2026)
- Ischemic Stroke: Current and Emerging Treatment Strategies (Deadline: 30 January 2026)
- NeuroImmunoEndocrinology (Deadline: 31 January 2026)
- The Regulatory Roles of the Gut Microbiota in Multisystem Diseases (Deadline: 31 January 2026)
- Novel Drug Candidates for the Treatment of Cardiac and Renal Diseases (Deadline: 31 January 2026)
- Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria: 2nd Edition (Deadline: 31 January 2026)
- Advances in Targeting Mitochondrial Sirtuins for Treatment of Metabolic Diseases Such as Type 2 Diabetes and Obesity (Deadline: 31 January 2026)
- Drug Therapy for Rheumatological Diseases (Deadline: 31 January 2026)
- Chemotherapeutic and Targeted Drugs in Antitumor Therapy (Deadline: 15 February 2026)
- Targeting Epigenetic Regulation for Cancer Therapy (Deadline: 25 February 2026)
- New Horizons in Drug Development Targeting Depression (Deadline: 28 February 2026)
- Molecular Insights and Clinical Implications in Geriatric Medicine and Drug Development (Deadline: 28 February 2026)
- Medications: Interactions with Diet, Herbs, Dietary Supplements and Probiotics (Deadline: 1 March 2026)
- Innovations in Chemotherapy: From Synthetic to Natural Agents and Combined Therapies (Deadline: 1 March 2026)
- Discovery and Validation of Novel Antimicrobial Molecules for the Treatment of Multidrug-Resistant Bacterial Infections (Deadline: 27 March 2026)
- Applications of Stem Cells and Organoids in Disease Modeling, Drug Discovery and Clinical Evaluation (Deadline: 31 May 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
